Sera Prognostics Reports Positive PRIME Trial Results
SALT LAKE CITY | July 9, 2026 Sera Prognostics Inc., a leader in precision pregnancy diagnostics, has announced the...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
SALT LAKE CITY | July 9, 2026 Sera Prognostics Inc., a leader in precision pregnancy diagnostics, has announced the...
SALT LAKE CITY, June 23, 2026 Sera Prognostics Inc. welcomed new legislative action in Illinois that expands Medicaid coverage...
